A randomized, open-label, single-visit crossover study simulating triple-drug delivery with Ellipta compared with dual inhaler combinations in patients with COPD

Abstract

Fewer patients with COPD made critical errors with the single DPI, and patients required less instruction time, compared with each dual DPI combination.